Tag - GSK

Developments

Roberto Bellini wins 2024 Bloom Burton Award

Bloom Burton has announced Roberto Bellini, former president and CEO of BELLUS Health, acquired by GlaxoSmithKline (GSK) (LSE/NYSE:GSK) in 2023, as the recipient of the 2024 Bloom Burton Award given annually to honor an...

September 27, 2024

Developments

Three finalists announced for Bloom Burton Award

The finalists for the 2023 Bloom Burton Award are: Stephen Dilly, former president and CEO, Sierra Oncology Ian Mortimer, president and CEO, Xenon Pharmaceuticals Dave Wessinger, co-founder and CEO, and Mike Wessinger...

May 4, 2023

Tag - GSK

Roberto Bellini wins 2024 Bloom Burton Award

Three finalists announced for Bloom Burton Award

General

More